FoRx Therapeutics
Developer of cancer drugs designed to focus on novel DNA replication stress pathways activated in cancer. The company focuses on drugging key molecular targets involved in DNA replication stress, as a...
Valuation
$0
Share Price
N/A
Total Raised
$60.3M
Last Round
N/A